On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > BUSINESS
BUSINESS
- Fujifilm to Shutter Gx, LLP Operations in March
July 30, 2018
- Mitsubishi Tanabe’s Erythropoietic Protoporphyria Earns FDA Fast-Track Status
July 30, 2018
- Chugai Forms Partnership with AI Upstart
July 30, 2018
- Chugai to Construct New Synthetic Research Building at Ukima Lab
July 30, 2018
- Chugai to Extend Operation Period of Singapore Research Subsidiary
July 30, 2018
- AI in Pharma - 1: Companies Going Digital in Sales Support but Still Embrace Rep Experience
July 30, 2018
- Chugai Filed Tecentriq for 1st Line Lung Cancer in March as Players Race to Grab Low PD-L1 Expressers
July 27, 2018
- Chugai Sees Solid Uptake for Tecentriq, Hemlibra but CEO Frets Pricing Stability
July 27, 2018
- Dasotraline Demonstrates Significant Improvement in Binge Eating Disorder in US PIII Study: Sunovion
July 27, 2018
- Elenbecestat Clears Brain Amyloid, Eisai/Biogen Reports Detailed PII Data
July 26, 2018
- Alunbrig Beats Xalkori in Front-Line NSCLC: Takeda
July 26, 2018
- (Update) Eisai/Biogen Alzheimer’s Drug BAN2401 Slows Cognitive Decline by 30%
July 26, 2018
- Astellas Is Best Pharma Company to Work for: Survey
July 26, 2018
- 2 Major Japan Wholesalers Hook Up on Specialty, Generic Drug Biz
July 25, 2018
- Solasia Grabs China Approval for Antiemetic Patch Drug
July 25, 2018
- Oncologist Lauds Imfinzi as Trailblazer in Stage III Lung Cancer, Eagerly Awaiting OS Data
July 24, 2018
- Sales Reps Required Spontaneous Safety Reports even in Surveys Using Database: Ms Takizawa of Otsuka
July 24, 2018
- Shionogi Ups Earnings Outlook on Xofluza Boost
July 24, 2018
- Daiichi Sankyo’s Herceptin Biosimilar Might Hit Market as Early as November, Breast Cancer Use Also Eyed
July 23, 2018
- Maruho to Increase Information Supply to Non-Dermatologists Using Digital Technology
July 23, 2018
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…